Treyfish
Moderator
Thursday, August 13, 2009 18:34
Bandung (ANTARA News) - Level spread of H1N1 virus in Indonesia reached 200 percent per ten days, but does not impact directly on the high number of death cases due to the virus.
"Data from a hospital in Indonesia, the mortality rate due to H1N1 virus is only 0.5 percent. However, the distribution is quite wide and fast so that should keep the anticipation," said Deputy Menristek field Sipteknas Prof. Development. Dr. Amin Soebandrio in between the Development of Vaccines Seminar on the Future of PT Bio Farma, Bandung, on Thursday.
He said, the level of the spread of swine flu or a flu to pigs, including higher. When was ranked 90 out of 140 countries in the world. However, on the other hand, the government and people of Indonesia have been able and compact mengantisipasinya.
Compared with the U.S., he said, the handling is better in every case because the anticipated direct and conducted post-treatment monitoring to ensure kesembuhannya.
"In other countries sometimes do not match the number of patients, the fact that more contagious," he said.
MOH through the Government of Indonesia and PT Bio Farma immediately take strategic steps, including setting up the production of swine flu vaccine or H1N1 that is now in the stage production of bulk.
PT Bio Farma-appointed government to produce swine flu vaccine and get three H1N1 vaccine strain. Previous development, the vaccine is actually projected to bird flu or H5N1.
"The technology and human resources that Indonesia is able to produce, research has been done. But it may kendalanya budget due to start production of the investment need not less," said Amin.
He said, the price of swine flu vaccine is still high between 8 to 10 U.S. dollars per dose. This means, to meet the demand for 10 percent of Indonesia or about 20 million of the funds needed Rp2 trillion.
Meanwhile, PT Bio Farma Dirut Isa Mansyur states, company is ready to produce swine flu vaccine.
"In general there is no obstacle, we nyambung research for the production of swine flu. The human resources we are ready, anggaranya live only for the memproduksinya. We hope the upcoming year 2010, mass production can have," he said.
Meanwhile, the first country that will produce the bulk of swine flu vaccine is in Australia this August 2009.
"We're not as fast as they can, but at least next year we can produce at least 4.5 million doses. But also depends on the readiness of ground virusnya media," said Isa Mansyur.
PT Bio Farma mengandeng among the universities with the University of Airlangga (Unair) Surabaya in the development of seed (seed) vaccine and the University of Padjadjaran seed for the purification of the vaccine using chicken eggs media.:tiphat:http://www.antaranews.com/berita/1250163259/penyebaran-virus-h1n1-capai-200-persen
Bandung (ANTARA News) - Level spread of H1N1 virus in Indonesia reached 200 percent per ten days, but does not impact directly on the high number of death cases due to the virus.
"Data from a hospital in Indonesia, the mortality rate due to H1N1 virus is only 0.5 percent. However, the distribution is quite wide and fast so that should keep the anticipation," said Deputy Menristek field Sipteknas Prof. Development. Dr. Amin Soebandrio in between the Development of Vaccines Seminar on the Future of PT Bio Farma, Bandung, on Thursday.
He said, the level of the spread of swine flu or a flu to pigs, including higher. When was ranked 90 out of 140 countries in the world. However, on the other hand, the government and people of Indonesia have been able and compact mengantisipasinya.
Compared with the U.S., he said, the handling is better in every case because the anticipated direct and conducted post-treatment monitoring to ensure kesembuhannya.
"In other countries sometimes do not match the number of patients, the fact that more contagious," he said.
MOH through the Government of Indonesia and PT Bio Farma immediately take strategic steps, including setting up the production of swine flu vaccine or H1N1 that is now in the stage production of bulk.
PT Bio Farma-appointed government to produce swine flu vaccine and get three H1N1 vaccine strain. Previous development, the vaccine is actually projected to bird flu or H5N1.
"The technology and human resources that Indonesia is able to produce, research has been done. But it may kendalanya budget due to start production of the investment need not less," said Amin.
He said, the price of swine flu vaccine is still high between 8 to 10 U.S. dollars per dose. This means, to meet the demand for 10 percent of Indonesia or about 20 million of the funds needed Rp2 trillion.
Meanwhile, PT Bio Farma Dirut Isa Mansyur states, company is ready to produce swine flu vaccine.
"In general there is no obstacle, we nyambung research for the production of swine flu. The human resources we are ready, anggaranya live only for the memproduksinya. We hope the upcoming year 2010, mass production can have," he said.
Meanwhile, the first country that will produce the bulk of swine flu vaccine is in Australia this August 2009.
"We're not as fast as they can, but at least next year we can produce at least 4.5 million doses. But also depends on the readiness of ground virusnya media," said Isa Mansyur.
PT Bio Farma mengandeng among the universities with the University of Airlangga (Unair) Surabaya in the development of seed (seed) vaccine and the University of Padjadjaran seed for the purification of the vaccine using chicken eggs media.:tiphat:http://www.antaranews.com/berita/1250163259/penyebaran-virus-h1n1-capai-200-persen
